Neogenomics Inc
NEO· Nasdaq
Filed Nov 5, 2012 · 10-Q · 36 days after period end · 0001193125-12-451638
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | -$975.00K | -$143.00K | -$1.20M |
| EPS Diluted | -$0.02 | $0.00 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 5, 2012 · 36 d after period end